REFERENCES
- Ju H, Jones M, Mishra G. The prevalence and Risk Factors of
Dysmenorrhea. Epidemiol Rev 2014;36 (1):104-113.
- Allen WM, Masters WH. Traumatic laceration of uterine support. Am J
Obstet Gynecol. 1955;70:500-13.
- Cagnacci A, Grandi G, Cannoletta, Xholli A, Piacenti I, Volpe A.
Intensity of menstrual pain and estimated angle of uterine flexion.
Acta Obstet Gynecol Scand 2014 Jan;93(1):58-63.
- Hammoud A, Gago LA, Diamond MP. Adhesions in patients with Chronic
Pelvic pain : a role for adhesiolysis? Fertil Steril 2004
Dec;82(6):1483-91.
- Chan WY. Prostaglandins and nonsteroidals antiinflammatory drugs in
dysmenorrhera. Annu Rev Pharmacol Toxicol 1983;23 :131-149.
- Borghi C, Dell’Atti L. Pelvic congestion syndrome : the current state
of the literature. Arch Gynecol Obstet 2016 Feb;293(2):291-301.
- Petros PE, Richardson PA. TFS posterior sling improves overactive
bladder, pelvic pain and abnormal emptying, even with minor prolapse-a
prospective urodynamic study. Pelviperineology 2010;29:52-5.
- Stratton P, Berkley KJ. Chronic Pelvic Pain and endometriosis:
translational evidence of the relationship and implications. Human
Reprod Update 2011 May-Jun;17(3):327-46.
- López A. Pain and Endometriosis. Convergences PP annual congress;
Madrid 2019 November 14-16th.
- Woolf CJ. Evidence for a central component of post-injury pain
hypersensitivity. Nature 1983;3065944:686-8.
- Woolf CJ. Central Sensitization : uncovering the relation between pain
and plasticity. Anesthesiology 2007;106(4):864-7.
- Woolf CJ. Central Sensitization : Implications for the diagnosis and
treatment of pain. Pain 2011 ; 152(suppl 3):S2-15.
- Woolf CJ. What to call amplification of nociceptive signals in the
central nervous system that contribute to wispread pain. Pain
2014;155(10):1911-2.
- Bonaz B. Visceral sensitivity perturbation integration in the
brain-gut axis in functional digestive disorders. J Physiol Pharmacol
2003 Dec ;54 Suppl 4:27-42.
- Kanazawa M, Hongo M, Fukudo S. Visceral hypersensitivity in irritable
bowel syndrome. J Gastroenterol Hepatol 2011 Apr;26 Suppl 3:119-21.
- Eisenbruch S. Abdominal pain in irritable bowel syndrome : a review of
putative psychological, neural and neuro-immune mechanisms. Brain
Behav Immun 2011 Mar;25(3):386-94.
- Keszthelyi D, Troost FJ, Simrén M, Ludidi S, Kruimel JW, Conchillo Jm
et al. Revisiting concepts of visceral nociception in irritable bowel
syndrome. Eur J Pain 2012 Nov;16(10):1444-54.
- Fitzgerald MP, Koch D, Senka J. Visceral and cutaneous sensory testing
in patients with painful bladder syndrome. Neurourol Urodyn
2005;24(7):627-32.
- Lai HH, Gardner V, Ness TJ, Gereau RW. Segmental hyperalgesia to
mechanical stimulus in interstitial cystitis/bladder pain syndrome :
evidence of central sensitization. J Urol 2014 May;191(5):1294-9.
- Grundy L, Caldwell A, Brierley SM. Mechanisms underlying overactive
bladder and interstitial Cystitis/painful bladder syndrome. Front
Neurosci 2018 Dec 12;12:931.
- Akiyama Y, Luo Y, Hanno PM, Maeda D, Homma Y. Interstitial
cystitis/bladder pain syndrome : The evolving landscape, animal models
and future perspectives. Int J Urol 2020 Apr 4. Doi :10.
- Iacovides S, Baker FC, Bentley A. Women with dysmenorrhea are
hypersensitive to experimental deep muscle pain across the menstrual
cycle. J Pain 2013 Oct;14(10):1066-76.
- Iacovides S, Avidon I, Baker FC. What we know about primary
dysmenorrhea today : a critical review. Hum Reprod Update 2015
Nov-Dec;21(6):762-78.
- Giamberardino MA, Tana C, Costantini R. Pain theresholds in women with
chronic pelvic pain. Curr Opin Obstet Gynecol 2014 Aug;26(4):253-9.
- Jarrell J, Arendt-Nielsen J. Allodynia and dysmenorrhea. J Obstet
Gynecol Can 2016 Mar;38(3):270-4.
- Jarrell J, Arendt-Nielsen J. Evolutionary considerations in the
development of chronic pelvic pain. Am J Obstet Gynecol. 2016
Aug;215(2):201.e1-4.
- Katoaka M, Togashi K, Kido A, Fujiwara T, Koyama T, Fujii S.
Dysmenorrhea : evaluation with cine-mode-display MR imaging initial
experience. Radiology 2005 Apr;235(1):124-31.
- Guo SW, Mao X, Ma Q, Liu X. Dysmenorrhea and its severity are
associated with increased uterine contractility and overexpression of
oxytocin receptor (OTR) in women symptomatic adenomyosis. Fertil
Steril 2013 Jan;99(1):231-40.
- Liu S, Zhang Q, Yin C, Chan Q, Chen W, He J, Zhu B. Optimized approach
to cine MRI of uterine peristalsis. J Magn Reson Imaging 2016
Dec ;44(6) :1397-1404.
- Bautrant E, Bryselbout MA, Thiers-Bautrant D, Eggermont E, Boyer R,
Cassin H et al. Chronic pelvic pain syndrome due to uterine
adenomyosis : diagnostic criteria and conservative treatment. Pelvi
Perineol 2011;6:42-45.
- Reynolds WS, Dmochowski R, Wein A, Bruehl S. Does central
sensitization help explain idiopathic overactive bladder ? Nat Rev
Urol 2016 Aug;13(8) :481-91.
- Kuo HC, Jiang YH, Tsai YC, Kuo YC. Intravesical botulinum toxin-A
injections reduce bladder painof interstitial cystitis/bladder pain
syndrome refractory to conventional treatment - A prospective,
multicenter, randomized, double-blind, placebo-controlled clinical
trial. Neurourol Urodyn 2016 Jun;35(5):609-14.
- Giannantoni A, Gubbiotti M, Bini V. Botulinum Neurotoxin A
intravesical injections in interstitial cystitis/bladder painful
syndrome : A systematic review with meta-analysis. Toxins (Basel) 2019
Sep 30;11(9):510.
- Bautrant E, Levêque C, Boyer R, Collet S, Bartoli D, Carbone P. Pilot
study of Botulinum Toxin A uterine muscle injection in the the
treatment of acute dysmenorrhea, uterine pain and deep dyspareunia.
Toxicon 2018;S2-S120:S7-8.
- Bautrant E. « Endometriosis like » syndrome : from the concept of
uterine pain syndrome to the use of Botulinic Toxin injections.
Convergences PP annual congress ; Madrid 2019 November 14-16th.
- Levesque A et al, Convergences PP Network. Cinical criteria of central
sensitization in chronic pelvic and perineal pain (Convergences PP
criteria): elaboration of a clinical evaluation tool based on formal
expert consensus. Pain Med 2018;19(10):2009-2015.
- Latremoliere A, Woolf CJ. Central sensitization : a generator of pain
hypersensitivity by central neural plasticity. J Pain 2009
sep10;(9):895-926.
- Pohl M Central nociceptive sensitization : cellular and molecular
signalization systems. Douleurs Evaluation-Diagnostic-Traitement
2014;15:44-51.
- Sengupta JN. Visceral pain : the neurophysiological mechanism.Handb Exp Pharmacol 2009;194:32-74.
- Janig W. Neurobiology of visceral pain. Schmerz 2014 Jun;28(3):233-51.
- Zang Z, Cai YQ, Zou F, Bie B, Pan ZZ. Epigenetic suppression of GAD65
expression mediates persistant pain. Nat Med 2011;17:1448-55.
- Affaitati G, Costantini R, Tana C, Cipollone F, Giamberardino MA.
Co-occurrence of pain syndromes. J Neural Transm (Vienna) 2020
Apr;127(4):625-646
- Evans SF, Brooks TA, Esterman AJ, Hull ML, Rolan PE. The comorbidities
of dysmenorrhea : a clinical survey comparing symptom profile in woman
with and without endometriosis. J Pain Res 2018 Dec 13;11:3181-3194.
- Stratton P, Khachikyan I, Sinaii N, Ortiz R, Shah j. Association of
chronic pelvic pain and endometriosis with signs of sensitization and
myofascial pain. Obstet Gynecol 2015 Mar;125(3):719-28.
- Grundström H, Gerdle B, Alehagen S, Berterö C, Arendt-Nielsen L et al.
Reduced pain thersholds and signs of sensitization in women with
persistent pelvic pain and suspected endometriosis. Acta Obstet
Gynecol Scand 2019 Mar;98(3):327-336.
- Giamberardino MA, Costantini R, Affaitati G, Fabrizio A, Tafuri E,
Mezzetti A. Viscero-visceral hyperalgesia: characterization in
different clinical models. Pain 2010 Nov;151(2):307-22.
- Bautrant E, O Porta, F Murina, H Mühlrad, C Levêque, T Riant, S
Ploteau, G Valancogne, A Levesque. Provoked vulvar vestibulodynia :
Epidemiology in Europe, physio-pathology, consensus for first line
treatment and evaluation of second-line treatments. J Gynecol Obstet
Hum Reprod 2019;48:685-88.
- Poulain B. Botulinum neurotoxin. Rev Neurol(Paris). 2010
Jan;166(1):7-20.
- Montal M. Botulinum neurotoxin : a marvel of protein design. Annu Rev
Biochem 2010;79:591-617.
- Pellett S, Yaksh TL, Ramachandran R. Current status and future
directions of botulinum neurotoxins for targeting pain processing.
Toxins (Basel) 2015;7(11):4519-4563.
- Aredo JV, Heyrana KJ, Karp BI, Shah JP, Stratton P. Relating chronic
pelvic pain and endometriosis to signs of sensitization and myofascial
pain and dysfunction. Semin Reprod Med 2017 Jan;35(1):88-97.
- Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TH. Botulinum
toxin type A for chronic pain and pelvic floor spasm in women : a
andomized controlled trial. Obstet Gynecol 2006 Oct;108(4):915-23.
- Bautrant E, Quintas-Marquès L, Eggermont J, Faller E, Weber P, Poirson
E, Boyer R, Carbone P. Use of botulinum toxin neurotoxin type A
injections to the perineal muscles in cases of perineal pain and
dysfunction associated with pelvic floor muscle overcontraction and
myalgia. Toxicon 2014;11:021.
- Morrissey D, El-Khawand D, Ginzburg N, Wehbe S, O’Hare P3rd, Whitmore
K. Botulinum toxin A injections into pelvic floor muscles under
electromyographic guidance for women with refractory high-tone pelvic
floor dysfunction : A 6-month prospective pilot study. Female Pelvic
Med Reconstr Surg 2015 Sep-Oct;21(5):277-82.
- Karp BI, Tandon H, Vigil D, Stratton P. Methodological approaches to
botulinum toxin for the treatment of chronic pelvic pain, vaginismus,
and vulvar pain disorders. Int Urogynecol J 2019 Jul;30(7):1071-1081.
- Tandon HK, Stratton P, Sinaii N, Shah J, Karp BI. Botulinum toxin for
chronic pelvic pain in women with endometriosis : a cohort study of a
pain-focused treatment. Reg Anesth Pain Med 2019 Jul 8 (ahead of
print).
- Abbott J. Gynecological indications for the use of botulinum toxin in
women with chronic pelvic pain. Toxicon 2009 Oct:54(5):647-53.
- Bhide AA, Puccini F, Khullar V, Elneil S, Digesu GA. Botulinum
neurotoxin type A injection of the pelvic floor muscle in pain due to
spasticity : a review of the current literature. Int Urogynecol J.
2013 Sep;24(9):1429-34.
- Dessie SG, Von Bargen E, Hacker MR, Haviland MJ, Elkadry E. A
randomized, double blind, placebo-controlled trial of
onabotulinumtoxin A trigger point injections for myofascial pelvic
pain. Am J Obstet Gynecol 2019 Nov;221(5):517.
- Levesque A, Ploteau S, Michel F, Siproudhis L, Bautrant E, Eggermont
J, Rabischong B, Volteau C, Perrouin-Verbe MA, Labat JJ. Botulinum
toxin infiltrations versus local anaesthetic infiltrations in pelvic
floor myofascial pain : Multicentre, randomized, double blind study.
Ann Phys Rehabil Med 2020 Jan 22 (ahead of print).
- Brin MF, Kirby RS, Slavotinek A, Miller-Messana MA, Parker L et al.
Pregnancy outcomes following exposure to onabotulinumtoxinA.
Pharmacoepidemiol Drug Saf 2016 Feb;25(2):179-87.
- Li W, Tang M. Application of botulinum toxin in pregnancy and its
impact in female reproductive health. Expert Opin Drug Saf 2020
Jan;19(1):83-91.
- Neblett R, Hartzell MM, Cohen H, Mayer TG, Williams M, Choi Y et al.
Ability of the Central Sensitization Inventory to Identify Central
Sensitivity Syndromes in an Outpatient Chronic Pain Sample. Clin J
Pain 2014;31(4) :323-32.